On October 1, researchers launched the world’s first large-scale randomized controlled trial to determine if specific nutritional therapies can alleviate bipolar depression. The ENERGISE-BD study, led by the Universities of Edinburgh and Birmingham, will compare a high-fat, low-carbohydrate approach against standard healthy eating guidelines to manage persistent depressive symptoms.
Backed by £7.9 million in funding, the 12-week study will enroll approximately 200 participants who experience long-term depressive episodes that often resist conventional medication. According to the details of the ENERGISE-BD clinical trial, dietitians will guide half of the group through a ketogenic diet, while the other half follows the nutritionally balanced NHS EatWell recommendations.
Shifting Brain Fuel to Ketones
The biological premise centers on altering how the brain generates its energy. By heavily restricting carbohydrates, the ketogenic diet forces the body to stop relying on glucose and instead produce ketones. Scientists hypothesize that these chemical byproducts might provide a more efficient energy source for brain tissue, potentially stabilizing mood and energy levels.
Monitoring Neurological Impact
Beyond tracking daily symptom changes and dietary adherence, researchers will perform brain scans on roughly half of the volunteers. This imaging aims to uncover how shifts in brain chemistry correlate with mental health improvements. By combining clinical outcomes with cost analysis, the study seeks to establish robust evidence for integrating specialized nutritional interventions into standard psychiatric care.